Carotid plaque measures predict coronary heart disease in CKD patients

This retrospective analysis examined 377 patients with chronic kidney disease, most in stage 2, to assess whether carotid plaque measures predict coronary heart disease. Researchers used propensity score matching to create comparable groups of 114 patients each, comparing those with CHD to those without. The study evaluated carotid plaque number and maximum plaque length as predictors.

Carotid plaque number showed a significant association with CHD, with an odds ratio of 2.074 (95% CI: 1.243–3.460, p = 0.005). Maximum plaque length also showed a positive association with an OR of 1.165 (95% CI: 1.073–1.265), though the exact p-value was not reported. No absolute numbers were provided for these outcomes.

Safety and tolerability data were not reported in this analysis. The study's key limitation is its observational, retrospective design, which prevents causal inference despite the use of propensity score matching to control for confounders. Other limitations, funding sources, and conflicts of interest were not reported.

For clinical practice, this analysis suggests carotid plaque measures may have predictive value for CHD in CKD patients, but the retrospective nature means these findings should be interpreted cautiously as associations rather than proven predictors. The study provides no guidance on how these measures might be integrated into clinical decision-making.